KTTA Stock: Pasithea Therapeutics Corp. Stock Price, Analysis & Insights
Get live ktta stock price $0.99, comprehensive Pasithea Therapeutics Corp. stock analysis, charts, news, and expert forecast. Real-time ktta stock data and investment insights.
Loading chart...
Company Overview
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Company Information
- CEO
- Tiago Reis Marques
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
Contact Information
- Website
- https://www.pasithea.com
- Address
- 1111 Lincoln Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.29) may provide portfolio stability
Business Model & Strategy
Pasithea Therapeutics Corp. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Tiago Reis Marques, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Pasithea Therapeutics Corp. competes in the Biotechnology within the broader Healthcare. With 7.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Pasithea Therapeutics Corp. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Pasithea Therapeutics Corp. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Pasithea Therapeutics Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Pasithea Therapeutics Corp.
- ⚠Investors should consider how Pasithea Therapeutics Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
7.37M
P/E Ratio
-0.22
Beta
0.29
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 7.37M market capitalization
- Trading Volume: 86.93M shares traded today
- Price Range: 52-week range of $0.28 - $3.85
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 7.37M, the company represents a significant player in its market. The stock is currently trading at $0.99 with a positivedaily change of 103.08%.
The company's 4 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.22, beta of 0.29, and 52-week price range from $0.28 to $3.85when evaluating investment opportunities.
Why Invest in Pasithea Therapeutics Corp.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Tiago Reis Marques
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.